This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Valneva Se. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Fabien Perugi: Innovator in Vaccine Development
Introduction
Fabien Perugi is a notable inventor based in Nantes, France. He has made significant contributions to the field of vaccine development, particularly in the area of respiratory tract infections. With a total of 3 patents to his name, Perugi is recognized for his innovative approaches to immunization.
Latest Patents
Among his latest patents, Perugi has developed a subunit vaccine aimed at the treatment or prevention of respiratory tract infections. This invention focuses on modified human metapneumovirus (hMPV) F proteins that are stabilized in the pre-fusion conformation. The patent details immunogenic compositions, or vaccines, that utilize these proteins to prevent and treat respiratory infections in human subjects.
Career Highlights
Fabien Perugi is currently associated with Valneva SE, a company dedicated to developing innovative vaccines. His work at Valneva has positioned him at the forefront of vaccine research, contributing to advancements that could significantly impact public health.
Collaborations
Perugi has collaborated with esteemed colleagues in his field, including Klaus Heinrich Schwamborn and Wolfgang Schüler. These partnerships have fostered a collaborative environment that enhances the development of effective vaccine solutions.
Conclusion
Fabien Perugi's contributions to vaccine innovation are noteworthy, particularly in the context of respiratory tract infections. His work continues to pave the way for advancements in immunization and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile